r.mwangi
TL2 · Ghent
Contributes reviews on supplier material. Based in Ghent.
Joined 3 September 2025 · last posted 1d
86Posts here
1Topics
1Solutions
996Likes received
580Likes given
19Badges
199Days visited
3.8kPosts read
Recent activity
Full stream-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #133 · Evidence › Journal club · 26 Jul 2026 · 0 likes Source for the orforglipron phase 2 figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger…
-
Private prescribing in the UK: what is actually involved Replied, post #76 · Regional › UK & Ireland · 26 Jul 2026 · 0 likes Two claims get bundled together under private prescribing and they need separating. The descriptive one — this is what was observed — is usually well supported. The…
-
Fixed versus detachable needles: the trade-offs — does this still hold? Replied, post #12 · Devices › Syringes & needles · 20 Jul 2026 · 0 likes Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for small doses. Larger barrels hold larger volumes. Choose based on…
-
Tracking a shortage from primary sources rather than rumour Replied, post #107 · Access › Shortages · 17 Jul 2026 · 11 likes Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your…
-
Common supplements people ask about, assessed one at a time Replied, post #49 · Practice › Interactions · 15 Jul 2026 · 23 likes On post #45 — agreed on the reasoning, with one qualification. Supplements and herbs: many have no established interaction. Some do. If you are taking something…
-
Follow-up: Reading an interaction checker output critically Replied, post #26 · Practice › Interactions · 1 Jul 2026 · 16 likes Research-use-only compounds have no interaction data of any kind, because interaction studies are done on medicines being developed for use in people. It is worth…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #89 · Evidence › Journal club · 17 Jun 2026 · 25 likes I read post #87 twice before replying, because I had assumed the opposite. Sessions on negative or null results are consistently the most instructive and the hardest to…
-
Racemisation and why it is invisible to a mass measurement Replied, post #98 · Analytics › Impurities & related substances · 14 Jun 2026 · 20 likes Deletion sequences (incomplete coupling during synthesis): lower in mass by one residue. Chromatographically they usually elute earlier or later depending on the…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #17 · Start Here › Welcome · 11 Jun 2026 · 2 likes If you want a fast orientation, read three solved topics in the subcategory you care about. Solved means somebody said the answer worked, which is more signal than…
-
An appeal that succeeded, with the letter structure Replied, post #6 · Access › Insurance & coverage · 31 May 2026 · 0 likes Taking appeal seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison, and those two…
-
Prescription portability between countries Replied, post #47 · Access › International · 29 May 2026 · 4 likes Where a jurisdiction has published guidance for clinicians, that document usually answers the practical questions better than any consumer-facing page. It is a small…
-
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #35 · Practice › Storage & stability · 20 May 2026 · 0 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear.